Alice GilmanCo-Founder & COO at R3 BiotechnologiesSpeaker
Profile
Alice Gilman is a CEO for a stealth experimental stem cell based startup aimed at transforming the medical industry and delay aging.
Alice is a visionary in regenerative medicine, longevity science, and advanced biotechnology, building the platforms that will define the next century of healthcare. Leading efforts to develop stem cell–based and genetically engineered systems capable of repairing, replacing, and enhancing human biology.
Her background blends startup leadership, global event organization, and cross-disciplinary collaboration. Organized over 80 conferences in more than 40 countries, connecting researchers, investors, and policymakers to accelerate the translation of cutting-edge science into real-world therapies. Particularly focused on closing the gap between breakthrough lab discoveries and scalable clinical applications, ensuring that regenerative medicine extends lifespan and improves quality of life at every age.
She is passionate about solving organ shortages, reversing age-related decline, and fostering ethical biotech innovation, working with a global network to push the boundaries of what is possible in human health.
Agenda Sessions
Transforming Aging: Longevity and Healthspan Therapeutics
, 08:00View Session
